使用hinotori™手术机器人系统行解剖性肺切除治疗原发性肺癌的早期临床结局:36例围术期结局的单中心前瞻性观察研究
本研究为单中心前瞻性观察研究,纳入2024年7月至2026年2月连续36例使用hinotori™机器人系统行解剖性肺切除的原发性肺癌患者,评估围术期结局并与有经验及首次使用该系统的术者比较。结果显示平均控制台时间和总手术时间分别为139.9分钟和203.1分钟,平均估计失血量68.3 mL,平均胸管留置时间4天,Clavien-Dindo III级及以上主要并发症4例(11.1%),无30天死亡或再入院。结论认为该系统可行且可重复。
要点
- 36例机器人解剖性肺切除中Clavien-Dindo III级及以上并发症4例(11.1%)。
- 平均控制台时间139.9分钟,总手术时间203.1分钟,估计失血量68.3 mL。
- 有经验与首次使用该系统的术者围术期结局相当,无30天死亡或再入院。
核心结论
- hinotori™机器人系统用于原发性肺癌解剖性肺切除安全且可重复,具备胸外科更广泛临床应用的潜力。
研究设计与样本
- 单中心前瞻性观察研究,连续纳入36例2024年7月至2026年2月用hinotori™系统行解剖性肺切除的原发性肺癌患者。
- 围术期数据取自机构记录,比较有经验机器人术者与首次使用hinotori™系统的术者。
主要发现
- 平均控制台时间和总手术时间分别为139.9分钟和203.1分钟。
- 平均估计失血量68.3 mL,平均胸管拔除时间4天。
- Clavien-Dindo III级及以上主要围术期并发症4例(11.1%),包括持续性漏气3例和脑梗死1例。
- 无hinotori™使用相关并发症,无30天死亡或再入院事件。
- 有经验与无经验术者的围术期结局相当。
临床怎么用
- 该系统可用于原发性肺癌解剖性肺切除,早期围术期结局可接受。
- 首次使用该系统的术者围术期结局与有经验术者相当,但需结合本单中心小样本结果谨慎推广。
局限性
- 单中心前瞻性观察研究,样本量36例,证据级别有限。
- 非随机对照设计,与有经验术者比较可能存在混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The hinotori™ surgical robot system is the second Japanese-made surgical robotic system to be approved for use in thoracic surgery, following Saroa. Although the feasibility of robotic systems has been demonstrated primarily in the field of abdominal surgery, evidence for thoracic surgery remains scarce. This study aimed to evaluate the early clinical outcomes of anatomical pulmonary resections performed with this system and to assess its feasibility as a routine platform for thoracic oncology. METHODS: A prospective observational study was conducted, including 36 consecutive patients undergoing anatomical lung resection for primary lung cancer with the hinotori™ system between July 2024 and February 2026. Perioperative data were extracted from institutional records and were compared between experienced robotic surgeons and surgeons performing their first robotic surgery with the hinotori™ system. RESULTS: The average console and total operative times were 139.9 min and 203.1 min, respectively. The mean estimated blood loss was 68.3 mL, and the average duration to chest drain removal was 4 days. Major perioperative complications, corresponding to Clavien-Dindo grade III or higher were observed in four cases (11.1%) including persistent air leakage in three cases and cerebral infarction in one case. No complications due to hinotori™ use, and no 30-day mortality or readmission events occurred. Perioperative outcomes were comparable between experienced and inexperienced surgeons. CONCLUSIONS: The hinotori™ surgical robot system enabled safe and reproducible anatomical lung resection for primary lung cancer indicating its potential for broader clinical use in thoracic surgery.
引用
- Miyahara S, Ueda Y, Mitsumata S, et al. Early clinical outcomes of anatomical lung resection for primary lung cancer using the hinotori™ surgical robot system: a single-institution prospective observational study of perioperative outcomes in 36 cases. Surg Endosc. 2026. PMID: 42120563. doi:10.1007/s00464-026-12869-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。